Literature DB >> 2253674

Pharmacokinetics of midazolam in critically ill neonates.

E Jacqz-Aigrain1, C Wood, I Robieux.   

Abstract

Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and children. An IV bolus of midazolam 0.2 mg.kg-1 was administered to 10 critically ill neonates receiving intensive care who required sedation. The plasma clearance was 6.85 ml.min-1 and the elimination half-life was 6.52 h. Midazolam was well tolerated during and after administration. Because of its short half-life compared to diazepam, midazolam could be used during the neonatal period to produce brief rapid sedation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253674     DOI: 10.1007/bf00280059

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  The pharmacokinetics of rectal midazolam for premedication in children.

Authors:  C Saint-Maurice; C Meistelman; E Rey; C Esteve; D de Lauture; G Olive
Journal:  Anesthesiology       Date:  1986-11       Impact factor: 7.892

2.  [Comparative pharmacokinetics of benzodiazepines].

Authors:  G Olive; E Rey
Journal:  Nouv Presse Med       Date:  1982-10-14

Review 3.  Pain and its effects in the human neonate and fetus.

Authors:  K J Anand; P R Hickey
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

Review 4.  Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.

Authors:  P L Morselli; R Franco-Morselli; L Bossi
Journal:  Clin Pharmacokinet       Date:  1980 Nov-Dec       Impact factor: 6.447

5.  A multicenter study of ICU drug utilization.

Authors:  M L Farina; A Levati; G Tognoni
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

6.  The pharmacokinetics of midazolam in paediatric patients.

Authors:  K Payne; F J Mattheyse; D Liebenberg; T Dawes
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Midazolam kinetics.

Authors:  H Allonen; G Ziegler; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

8.  Hepatic microsomal drug oxidation and electron transport in newborn infants.

Authors:  J V Aranda; S M MacLeod; K W Renton; N R Eade
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

9.  Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography.

Authors:  C V Puglisi; J Pao; F J Ferrara; J A de Silva
Journal:  J Chromatogr       Date:  1985-11-08

Review 10.  Midazolam: pharmacology and uses.

Authors:  J G Reves; R J Fragen; H R Vinik; D J Greenblatt
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

View more
  28 in total

1.  Pharmacokinetics of midazolam in critically ill pediatric patients.

Authors:  M C Nahara; J McMorrow; P R Jones; D Anglin; R Rosenberg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

2.  Use of methohexital for elective intubation in neonates.

Authors:  G Naulaers; E Deloof; C Vanhole; E Kola; H Devlieger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

3.  The use of midazolam in the preterm neonate.

Authors:  J N van den Anker; P J Sauer
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

4.  Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?

Authors:  Sven Björkman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.

Authors:  E Jacqz-Aigrain; P Daoud; P Burtin; S Maherzi; F Beaufils
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  The child in diagnostic nuclear medicine.

Authors:  B Ljung
Journal:  Eur J Nucl Med       Date:  1997-06

7.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

8.  Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

9.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 10.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.